Lapeyronie’s disease

Area of Science:

• Urology
• Andrology
• Regenerative Medicine

Context:

• Lapeyronie's disease affects 3.4-9% of men, causing acquired penile curvature from fibrous plaque.
• Pathophysiology remains debated, and conventional medical treatments are largely ineffective.
• Current management focuses on improving curvature and addressing associated sexual dysfunction.

Purpose:

• To review the current understanding and treatment options for Lapeyronie's disease.
• To highlight the role of intralesional Clostridium Histolyticum collagenase as a non-surgical therapeutic.
• To outline surgical and implant-based strategies for complex or refractory cases.

Summary:

• Lapeyronie's disease involves acquired penile curvature due to a fibrous plaque, impacting a significant portion of the male population.
• Intralesional Clostridium Histolyticum collagenase represents a novel, non-surgical approach for curvature improvement.
• Treatment selection, including surgery or penile implants, depends on curvature severity, penile size, and erectile function.

Impact:

• Provides an overview of Lapeyronie's disease management, emphasizing non-surgical advancements.
• Informs clinicians about the efficacy of intralesional collagenase for penile curvature.
• Guides treatment decisions for patients with Lapeyronie's disease, including surgical and implant options for severe cases.